Stool pathogen testing is important for diagnosing the various causes of diarrheal illnesses. Traditional stool pathogen testing has involved different laboratory methods, leading to specific multiple workflows for bacteria, viruses and parasites.
The introduction of molecular techniques has significantly improved the ability to detect a wide range of gastrointestinal pathogens while offering improved assay performance compared to the non-molecular methods of antigen, culture and/or microscopy.
This webinar will provide an overview of current testing methodologies used in clinical microbiology laboratories and demonstrate how molecular methods could enhance laboratory workflows and aid in patient diagnosis.
Register for this webinar today to understand the clinical and public health significance of molecular gastrointestinal pathogen testing and its impact on diagnosing diarrheal illnesses.
Speaker
Rodney Arcenas, PhD, D(ABMM), Clinical Development Lead, Roche Diagnostics Solutions
Rodney Arcenas is a board-certified Diplomate of the American Board of Medical Microbiology. He currently works at Roche Diagnostics Solutions as a Clinical Development Lead, where he has been supporting various Clinical Microbiology and Infectious Diseases projects for eight years.
Before joining Roche, Rodney served as the Clinical Microbiology Director for 10 years at the Memorial Healthcare System in Hollywood, Florida, where he led the Microbiology and Molecular Infectious Disease testing services.
Read more...
Read Less...
Who Should Attend?
This webinar will appeal to:
- Clinical Laboratorians (Directors, Medical Technologists, Clinical Laboratory Scientists, etc.)
What You Will Learn
Attendees will learn about:
- The clinical utility and importance of stool pathogen testing
- How molecular gastrointestinal (GI) pathogen testing can offer increased sensitivity and specificity compared to non-molecular GI methods
- How molecular GI testing may improve laboratory workflow efficiencies
Xtalks Partner
Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche a leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
With the addition of the cobas® eplex system, Roche expands its portfolio to multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. The cobas eplex system, a true sample-to-answer solution, is designed for the patient and optimized for the laboratory. The cobas eplex system addresses respiratory and bloodstream infections (gastrointestinal and meningitis & encephalitis panels are in development) with compact, easy-to-use workstations and self-contained test cartridges . The company’s headquarters are located in Carlsbad, CA.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account